日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in Thailand

利用泰国高价抗癌药物的真实数据对管理准入协议技术进行成本比较评估

Owat, Piyapat; Sooksriwong, Chaoncin; Ratanabunjerdkul, Hataiwan; Phodha, Tuangrat

Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study

在泰国人群中,接受根治性放化疗后使用度伐利尤单抗治疗III期非小细胞肺癌患者:一项真实世界多中心观察性研究

Sitthideatphaiboon, Piyada; Reungwetwattana, Thanyanan; Jaruhathai, Sureerat; Supavavej, Archara; Limpawittayakul, Piyarat; Maneenil, Kunlatida; Korphaisarn, Krittiya; Suksombooncharoen, Thatthan; Thongthieang, Luangyot; Sathitruangsak, Chirawadee; Chayangsu, Chawalit; Ratanabunjerdkul, Hataiwan; Prasongsook, Naiyarat; Sriuranpong, Virote

The national budget impact of managed entry agreement strategies match with high-cost drugs to maximise drug cost saving: a study protocol

国家预算对通过管理准入协议策略匹配高价药物以最大限度节省药品成本的影响:一项研究方案

Owat, Piyapat; Sooksriwong, Chaoncin; Ratanabunjerdkul, Hataiwan; Phodha, Tuangrat

Differentiation Induction of Human Stem Cells for Corneal Epithelial Regeneration

诱导人干细胞分化以促进角膜上皮再生

Theerakittayakorn, Kasem; Thi Nguyen, Hong; Musika, Jidapa; Kunkanjanawan, Hataiwan; Imsoonthornruksa, Sumeth; Somredngan, Sirilak; Ketudat-Cairns, Mariena; Parnpai, Rangsun

A Xeno-Free Strategy for Derivation of Human Umbilical Vein Endothelial Cells and Wharton's Jelly Derived Mesenchymal Stromal Cells: A Feasibility Study toward Personal Cell and Vascular Based Therapy

一种无异种成分的人脐静脉内皮细胞和华通氏胶来源间充质干细胞制备策略:面向个体化细胞和血管治疗的可行性研究

Kunkanjanawan, Hataiwan; Kunkanjanawan, Tanut; Khemarangsan, Veerapol; Yodsheewan, Rungrueang; Theerakittayakorn, Kasem; Parnpai, Rangsun